Sayansan, Raphy P.

HRN: 23-65-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/05/2023
09/12/2023
ORAL
100,000 IU
QID
Oral Candidiasis
Waiting Final Action 
09/07/2023
CEFTRIAXONE 1G (VIAL)
09/07/2023
09/14/2023
IV
1 Gram
Q12H
Immunocompromised State
Waiting Final Action 
09/07/2023
FLUCONAZOLE 50MG (CAP)
09/07/2023
09/14/2023
ORAL
200mg
OD
Oral Candidadiasi; Immunocompromised State
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: